Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different ...

A company presentation will take place during the conference’s Innovation track on Friday, March 28th at 9:00am. NeauxCancer conference’s Innovation track spotlights the most promising emerging ...

在抗击癌症这一人类健康的“头号杀手”之战中，武汉博威德生物技术有限公司的最新成果令人振奋。2025年2月26日，博威德生物研发的抗肿瘤创新药重组柯萨奇病毒B3注射液，商标名“爱速可”，成功获得美国食品药品监督管理局（FDA）的临床试验批准，标志着对付恶性肿瘤的治疗手段又添一把利器。

ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced its adoptive cell therapy, ELIAS Cancer Immunotherapy (ECI®), has received full approval from the U.S.